Dr. Orio’s area of research and excellence is genitourinary radiation oncology. He continues to explore innovations in the field of prostate cancer, leads the DF/BWCC prostate brachytherapy program and serves as Chairman of the Board for the American Brachytherapy Society. Dr. Orio focuses his clinical efforts on advancing innovative solutions for the safe delivery of radiation therapy and is passionate about educating clinicians and patients on radiation’s efficacy in treating genitourinary cancers.
Dr. Orio is the Vice Chair of Network Operations, Medical Director and Director of Genitourinary Brachytherapy for the Dana-Farber/Brigham and Women’s Cancer Centers Department of Radiation Oncology. He is a Senior Physician at Dana-Farber Cancer Institute and is an Assistant Professor of Radiation Oncology at Harvard Medical School.
Dr. Orio specializes in the treatment of prostate cancer utilizing Image Guided Radiation Therapy, Intensity Modulated Radiation Therapy, Advanced Image-Guided Brachytherapy and technologies utilizing hydrogels to space tumors away from normal tissues.
Male